ICER finds Vertex’s non-opioid pain treatment could bring cost savings at a lower price

The cost-effectiveness watchdog ICER found that Vertex’s future non-opioid treatment for acute pain could be cost-saving, but only at a low price, according to a …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Children’s wellbeing affected by the lingering effects of COVID-19 pandemic

While COVID-19 lockdowns are no longer mandated, the stress and anxiety of the pandemic still lingers, especially among young South Australians, say health experts at

August 25, 2023

Butterfly Network, Forest Neurotech Ink $20M Agreement to Develop Brain Implantable Powered By Ultrasound Chip

October 26, 2023

DEFENCE’S SUCCESSFUL RESULTS ON ITS ACCUTOX® ANTI-CANCER ARMTM VACCINE CREATES A POTENT SECOND-GENERATION ANTI-CANCER ARM-002TM VACCINE – Biotech Investments

EQS-News: Defence Therapeutics Inc. / Key word(s): Product Launch DEFENCE’S SUCCESSFUL RESULTS ON ITS ACCUTOX® ANTI-CANCER ARMTM VACCINE CREATES A POTENT SECOND-GENERATION ANTI-CANCER ARM-002TM VACCINE

March 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.